Company: GURE
Filing Date: 2025-12-29
Form Type: 8-K
Source: 0001193805-25-001792
Chunk: 0

Company: GULF RESOURCES, INC.
Filing Date: 2025-12-29
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

As previously reported, on December
10, 2025, pursuant to and subject to the terms of the previously announced equity transfer agreement, dated as of December 10, 2025 (the
“ SPA”), by and among Shouguang City Haoyuan Chemical Company Limited (the “ Seller”), a company incorporated
in the PRC and an indirect wholly owned subsidiary of Gulf Resources, Inc. (the “ Company”), Shandong Rongyuan Pharmaceutical
Co., Ltd. (the “ Purchaser”) and Shouguang Yuxin Chemical Industry Co., Limited (the “ Target Company”), the Purchaser
agreed to purchase from the Seller 100% equity interest in the Target Company (“ Transaction”). The Company’s Current
Report on Form 8-K, filed with the Securities and Exchange Commission on December 15, 2025, contains a description of the Transaction
and related matters.

The relevant governmental body, AMR (as defined in the SPA) completed
the industrial and commercial change registration of the Target Company on December 22, 2025, indicating the Purchaser as the sole shareholder
of the Target Company. As such, and pursuant to the SPA, the Transaction closed on December 22, 2025.

The Company is filing this Current
Report on Form 8-K to provide, in connection with the closing of the Transaction:

  the financial statements of the Company as of and for the year ended December 31, 2024 and nine months ended September 30, 2025, the  
  accompanying notes thereto, are incorporated herein by reference; and                                                                 
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  pro forma financial information as of and for the year ended December 31, 2024 and nine months ended September 30, 2025, are filed  
  as Exhibit 99.1.                                                                                                                    
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Statements contained herein relating
to the Company or its management’s intentions, hopes, beliefs, expectations or predictions of the future, constitute forward looking
statements. Such forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, risks contained
in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on